These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7358828)

  • 1. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 Mar; 50(3):427-30. PubMed ID: 7358828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Kato K; Shima K
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opiates modulate pulsatile luteinizing hormone release in humans.
    Ropert JF; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1981 Mar; 52(3):583-5. PubMed ID: 6780598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
    Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
    J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constancy of opioid control of luteinizing hormone in different pathophysiological states.
    Lightman SL; Jacobs HS; Maguire AK; McGarrick G; Jeffcoate SL
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1260-3. PubMed ID: 6785301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naloxone on prolactin-secreting pituitary adenomas.
    Shima K; Chigasaki H; Seki K
    Neurol Med Chir (Tokyo); 1990 Feb; 30(2):109-12. PubMed ID: 1695330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR; Ferin M
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid peptides in pseudocyesis.
    Devane GW; Vera MI; Buhi WC; Kalra PS
    Obstet Gynecol; 1985 Feb; 65(2):183-8. PubMed ID: 3918282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
    Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
    Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.
    Reid RL; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1107-10. PubMed ID: 6313728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.